Progenics Pharmaceuticals
(PGNX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2001 | 03-2001 | 12-2000 | 09-2000 | 06-2000 | |
| Sales | 1,407 | 5,847 | -604 | 3,701 | 3,352 |
| Gross Profit | 1,407 | 5,847 | -604 | 3,701 | 3,352 |
| Operating Expenses | 5,996 | 5,374 | 5,963 | 4,264 | 4,721 |
| Operating Income | -4,590 | 473 | -6,567 | -563 | -1,370 |
| Interest Expense | 12 | 12 | 24 | 24 | 25 |
| Other Income | 9,852 | 0 | 4,127 | 0 | 0 |
| Pre-tax Income | 5,251 | 461 | -2,463 | -587 | -1,395 |
| Net Income Continuous | 5,251 | 461 | -2,463 | -587 | -1,395 |
| Net Income | $5,251 | $461 | $-2,463 | $-587 | $-1,395 |
| EPS Basic Total Ops | 0.42 | 0.04 | -0.21 | -0.05 | -0.11 |
| EPS Basic Continuous Ops | 0.42 | 0.04 | -0.20 | -0.05 | -0.11 |
| EPS Diluted Total Ops | 0.38 | 0.03 | -0.21 | -0.05 | -0.11 |
| EPS Diluted Continuous Ops | 0.38 | 0.03 | -0.20 | -0.05 | -0.11 |
| EBITDA(a) | $-4,363 | $703 | $-6,181 | $-307 | $-1,073 |